Metabolic syndrome associates with left atrial dysfunction

Show full item record



Permalink

http://hdl.handle.net/10138/299272

Citation

Nyman , K , Granér , M , Pentikäinen , M O , Lundbom , J , Hakkarainen , A , Sirén , R , Nieminen , M S , Taskinen , M-R , Lundbom , N & Lauerma , K 2018 , ' Metabolic syndrome associates with left atrial dysfunction ' , Nutrition, Metabolism and Cardiovascular Diseases , vol. 28 , no. 7 , pp. 727-734 . https://doi.org/10.1016/j.numecd.2018.02.008

Title: Metabolic syndrome associates with left atrial dysfunction
Author: Nyman, K.; Granér, M.; Pentikäinen, M.O.; Lundbom, J.; Hakkarainen, A.; Sirén, R.; Nieminen, M.S.; Taskinen, M.-R.; Lundbom, N.; Lauerma, K.
Other contributor: University of Helsinki, Department of Diagnostics and Therapeutics
University of Helsinki, HUS Heart and Lung Center
University of Helsinki, Clinicum
University of Helsinki, Department of Diagnostics and Therapeutics
University of Helsinki, Clinicum
University of Helsinki, Clinicum
University of Helsinki, Department of Medicine
University of Helsinki, Clinicum
University of Helsinki, Clinicum
University of Helsinki, Clinicum











Date: 2018-07
Language: eng
Number of pages: 8
Belongs to series: Nutrition, Metabolism and Cardiovascular Diseases
ISSN: 0939-4753
DOI: https://doi.org/10.1016/j.numecd.2018.02.008
URI: http://hdl.handle.net/10138/299272
Abstract: Background and aims: Obesity and metabolic syndrome (MetS) are risk factors of atrial fibrillation (AF), but limited data exist on their effect on left atrial (LA) function. The aim of the study was to evaluate the effects of cardiac, hepatic and intra-abdominal ectopic fat depots and cardiometabolic risk factors on LA function in non-diabetic male subjects. Methods and results: Myocardial and hepatic triglyceride contents were measured with 1.5T H-1-magnetic resonance spectroscopy and LA and left ventricular function, visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), epicardial and pericardial fat by magnetic resonance imaging (MRI) in 33 men with MetS and 40 men without MetS. LA volumes were assessed using a novel three-chamber orientation based MRI approach. LA ejection fraction (EF) was lower in MetS patients than in the control group (44 +/- 7.7% in MetS vs. 49 +/- 8.6% in controls, p = 0.013) without LA enlargement, indicating LA dysfunction. LA EF correlated negatively with waist circumference, body mass index, SAT, VAT, fasting serum insulin, and homeostasis model assessment of insulin resistance index, and positively with fasting serum high-density lipoprotein cholesterol. VAT was the best predictor of reduced LA EF. Conclusions: MetS associates with subclinical LA dysfunction. Multiple components of MetS are related to LA dysfunction, notably visceral obesity and insulin resistance. Further studies are needed to elucidate the role of mechanical atrial remodeling in the development of AF. (C) 2018 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
Subject: Cardiovascular magnetic resonance
proton magnetic resonance spectroscopy
metabolic syndrome
obesity
left atrial
ejection fraction
atrial remodeling
visceral adipose tissue
cardiac steatosis
3121 General medicine, internal medicine and other clinical medicine
3126 Surgery, anesthesiology, intensive care, radiology
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
1_s2.0_S0939475318300590_main.pdf 818.1Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record